Medicare will generally help cover the cost of psoriasis medications. Learn more about eligibility for coverage and cost.

Adverse events from disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis decline by as much as 25% after the drugs are established on the market, according to data published ...

Find out about how biotech is done in space through the example of Exobiosphere and its €2 million seed round.

Although HHS says it did not target FDA product reviewers or inspectors, FDA employees who assist with reviews in various capacities were let go, including project managers and staff in administration ...

One of the worst complications of adult-onset Still's disease is macrophage activation syndrome (MAS), which can be fatal. In ...

Two phase 2 trials with different selective TYK2 inhibitors produce high rates of efficacy in moderate to severe plaque ...

The Inflation Reduction Act was intended to lower prescription drug costs, but an unintended consequence is threatening the ...

The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.

Risankizumab was associated with more significant improvements among patients with plaque psoriasis when compared with other biologic therapies.

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave ...

Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...